| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |